Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neovascular (Wet) AMD”

174 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 174 results

Post-approval studies (Phase 4)Study completedNCT02305238
What this trial is testing

Japanese Treat and Extend Study of Aflibercept in Neovascular Age-related Macular Degeneration

Who this might be right for
Wet Macular Degeneration
Bayer 288
Testing effectiveness (Phase 2)UnknownNCT00996684
What this trial is testing

Study of Intravitreal Microplasmin in Relieving Vitreo-Macular Adhesion in Neovascular Age-related Macular Degeneration

Who this might be right for
Macular Degeneration
University of California, Los Angeles 30
Post-approval studies (Phase 4)Study completedNCT04679935
What this trial is testing

Efficacy and Safety of Two Different Brolucizumab 6 mg Dosing Regimens in Neovascular Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Novartis Pharmaceuticals 52
Testing effectiveness (Phase 2)Ended earlyNCT01025232
What this trial is testing

Intravitreal Injections of 2.0mg Ranibizumab in Subjects With Chronic Fluid On OCT Post Multiple Injections With Ranibizumab (Super-dose Anti-VEgf SAVE Trial)

Who this might be right for
Age Related Macular DegenerationChoroidal Neovascular MembraneSubfoveal Neovascular Age-Related Macular Degeneration+2 more
David M. Brown, M.D. 88
Testing effectiveness (Phase 2)Study completedNCT03066258
What this trial is testing

Safety and Tolerability of RGX-314 (Investigational Product) Gene Therapy for Neovascular AMD Trial

Who this might be right for
Neovascular Age-related Macular DegenerationWet Age-related Macular Degeneration
REGENXBIO Inc. 42
Large-scale testing (Phase 3)Study completedNCT03823300
What this trial is testing

Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (LUCERNE)

Who this might be right for
Wet Macular Degeneration
Hoffmann-La Roche 658
Very early researchNot Yet RecruitingNCT06888492
What this trial is testing

To Evaluate the Safety and Preliminary Efficacy of Intravitreal EXG202 Injection in Patients with Wet (neovascular) Age-related Macular Degeneration (wAMD)

Who this might be right for
Wet Age-related Macular Degeneration (wAMD)Wet Age-related Macular Degeneration
Hangzhou Jiayin Biotech Ltd 8
Post-approval studies (Phase 4)Study completedNCT05269966
What this trial is testing

Study to Evaluate the Safety and Effectiveness of Intravitreal Injections (IVI) of Brolucizumab in Patients With Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)
Novartis Pharmaceuticals 105
Early research (Phase 1)Active Not RecruitingNCT05903794
What this trial is testing

EXG102-031 in Patients With wAMD (Everest)

Who this might be right for
Neovascular (Wet) Age-related Macular Degeneration (nAMD)
Exegenesis Bio 12
Large-scale testing (Phase 3)Not Yet RecruitingNCT07129239
What this trial is testing

High Dose (HD) Aflibercept Switch in Neovascular Age-related Macular Degeneration (nAMD): to Load or Maintain (HEIRLOOM)

Who this might be right for
Wet Age-related Macular Degeneration (wAMD)
Clinique de Retine de l'est 180
Testing effectiveness (Phase 2)Study completedNCT05275205
What this trial is testing

Safety, Tolerability, and Efficacy Study of UBX1325 in Patients With Neovascular Age-Related Macular Degeneration (ENVISION)

Who this might be right for
Neovascular Age-related Macular Degeneration
Unity Biotechnology, Inc. 51
Large-scale testing (Phase 3)Ended earlyNCT01944839
What this trial is testing

Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® Monotherapy

Who this might be right for
Age-Related Macular Degeneration
Ophthotech Corporation 619
Not applicableLooking for participantsNCT02253030
What this trial is testing

OCT Angiography in Wet AMD

Who this might be right for
Neovascular (Wet) Age-related Macular Degeneration (AMD)
Oregon Health and Science University 160
Large-scale testing (Phase 3)Study completedNCT07389577
What this trial is testing

Compare JL14002 to Lucentis® in Subjects With Wet Age-related Macular Degeneration (wAMD)

Who this might be right for
Wet Age-related Macular Degeneration
Jecho Biopharmaceuticals Co., Ltd. 443
Testing effectiveness (Phase 2)Study completedNCT06176963
What this trial is testing

Evaluate the Usability of the SB11 PFS in Subjects With Wet AMD or Macular Oedema Secondary to RVO

Who this might be right for
Neovascular Age-related Macular DegenerationMacular EdemaRetinal Vein Occlusion
Samsung Bioepis Co., Ltd. 34
Large-scale testing (Phase 3)Study completedNCT01835067
What this trial is testing

Intravitreal tPA and C3F8 for the Treatment of Submacular Haemorrhage as a Complication of Neovascular AMD

Who this might be right for
Exudative Macular DegenerationRetinal Hemorrhage
King's College Hospital NHS Trust 55
Post-approval studies (Phase 4)Study completedNCT03022292
What this trial is testing

The IAI-OCTA Study; a Study of OCT-Angiography Analysis Efficacy

Who this might be right for
Wet Macular Degeneration
University of California, Los Angeles 26
Not applicableLooking for participantsNCT06346600
What this trial is testing

A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD

Who this might be right for
Neovascular (Wet) Age-related Macular Degeneration
Skyline Therapeutics 83
Not applicableStudy completedNCT00656903
What this trial is testing

High Speed Indocyanine Green Angiography Findings in Ranibizumab Treatment for Wet Age-related Macular Degeneration

Who this might be right for
Macular Degeneration
National Eye Institute (NEI) 75
Testing effectiveness (Phase 2)Study completedNCT03345082
What this trial is testing

A Dose Ranging Study of OPT-302 With Ranibizumab in Neovascular (Wet) AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Opthea Limited 366
Load More Results